BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6921142)

  • 1. Active-site labeling of rat and human urinary kallikrein by chloro(N alpha-p-tosyllysyl)methane.
    Chao J
    Hoppe Seylers Z Physiol Chem; 1981 Aug; 362(8):1113-8. PubMed ID: 6921142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kininogen-derived fluorogenic substrates for investigating the vasoactive properties of rat tissue kallikreins--identification of a T-kinin-releasing rat kallikrein.
    El Moujahed A; Brillard-Bourdet M; Juliano MA; Moreau T; Chagas JR; Gutman N; Prado ES; Gauthier F
    Eur J Biochem; 1997 Jul; 247(2):652-8. PubMed ID: 9266709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kallikrein-induced uterine contraction independent of kinin formation.
    Chao J; Buse J; Shimamoto K; Margolius HS
    Proc Natl Acad Sci U S A; 1981 Oct; 78(10):6154-7. PubMed ID: 6947218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydrolysis of rat high molecular weight kininogen by purified rat urinary kallikrein: identification of bradykinin as the kinin formed.
    Girolami JP; Alhenc-Gelas F; Dos Reis ML; Bascands JL; Suc JM; Corvol P; Menard J
    Adv Exp Med Biol; 1986; 198 Pt A():137-45. PubMed ID: 3643701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rat uterine contraction by kallikrein and its dependence on uterine kininogen.
    Figueiredo AF; Salgado AH; Siqueira GR; Velloso CR; Beraldo WT
    Biochem Pharmacol; 1990 Feb; 39(4):763-7. PubMed ID: 1689579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinins contribute to the contractile effects of rat glandular kallikrein on the isolated rat uterus.
    Orce GG; Carretero OA; Scicli G; Scicli AG
    J Pharmacol Exp Ther; 1989 May; 249(2):470-5. PubMed ID: 2724135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The myostimulating effect of tissue kallikrein on rat uterus.
    Damas J; Bourdon V; Pinto JC
    Naunyn Schmiedebergs Arch Pharmacol; 1995 May; 351(5):535-41. PubMed ID: 7643918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of human and rat tissue kallikreins by peptide analog antagonists of bradykinin.
    Spragg J; Vavrek RJ; Stewart JM
    Adv Exp Med Biol; 1989; 247B():277-81. PubMed ID: 2610073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specificity of the amidase and kininogenase methods for the determination of rat urinary kallikrein.
    Berthoud VM; Corthorn JL
    J Clin Chem Clin Biochem; 1987 Sep; 25(9):595-600. PubMed ID: 3681198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The action of iodinated kallikrein on the rat uterus.
    Feitosa MH; Pesquero JL; Oliveira GM; Beraldo WT; Heneine IF
    Agents Actions Suppl; 1992; 36():265-70. PubMed ID: 1609650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation of tissue kallikrein in rat spleen by monoclonal antibody-affinity chromatography.
    Chao J; Chao L; Margolius HS
    Biochim Biophys Acta; 1984 Sep; 801(2):244-9. PubMed ID: 6566577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of [hydroxyproline3]-lysyl-bradykinin released from human kininogens by human urinary kallikrein.
    Maier M; Reissert G; Jerabek I; Lottspeich F; Binder BR
    FEBS Lett; 1988 May; 232(2):395-8. PubMed ID: 3378631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measurement of kallikrein activity in urine of rats and man using a chromogenic tripeptide substrate. Validation of the amidolytic assay by means of bradykinin radioimmunoassay.
    Bönner G; Marin-Grez M
    J Clin Chem Clin Biochem; 1981 Mar; 19(3):165-8. PubMed ID: 6908912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Release of [hydroxyproline3]-kinins by tissue kallikreins of pig, rat and man.
    Maier M; Reissert G; Jerabek I; Bergmann I; Balaun E; Lottspeich F; Binder BR
    Biochem Pharmacol; 1990 Feb; 39(3):549-53. PubMed ID: 2306266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A simple and sensitive method for determination of human urinary kallikrein activity (kininogenase activity), using human low molecular weight kininogen.
    Kondo M; Shimamoto K; Ura N; Nishimiya T; Mita T; Nakagawa M; Maeda T; Yamaguchi Y; Iimura O
    Endocrinol Jpn; 1984 Oct; 31(5):635-43. PubMed ID: 6569840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kininogenase from rat vascular tissue.
    Nolly H; Scicli AG; Scicli G; Lama MC; Guercio AM; Carretero OA
    Adv Exp Med Biol; 1986; 198 Pt A():11-7. PubMed ID: 3643700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kininogenase activity of prostate-derived human glandular kallikrein (hK2) purified from seminal fluid.
    Charlesworth MC; Young CY; Miller VM; Tindall DJ
    J Androl; 1999; 20(2):220-9. PubMed ID: 10232657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new assay for urinary kallikrein.
    Morris DH; Stewart JM
    Adv Biosci; 1978 Jul; 17():139-43. PubMed ID: 755690
    [No Abstract]   [Full Text] [Related]  

  • 19. Tonin and kallikrein-kinin system.
    Feitosa MH; Pesquero JL; Ferreira MA; Oliveira GM; Rogana E; Beraldo WT
    Adv Exp Med Biol; 1989; 247A():573-80. PubMed ID: 2557755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purification of human low molecular weight kininogen and its application for a simple ND sensitive method for determination of human urinary kallikrein activity.
    Nakagawa M; Shimamoto K; Kondo M; Ura N; Nishitani T; Ishida H; Yokoyama T; Tanaka S; Iimura O
    Adv Exp Med Biol; 1986; 198 Pt B():523-9. PubMed ID: 3643739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.